BEIGF Insider Transactions — Page 5
1,846 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 401–500; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Wang Xiaodong | Director,Other | 2025-01-07 | Sale | 5,638.0 | $178.39 |
| Wang Xiaodong | Director,Other | 2025-01-07 | Sale | 4,260.0 | $177.42 |
| Wang Xiaodong | Director,Other | 2025-01-07 | Sale | 11,310.0 | $176.67 |
| Wang Xiaodong | Director,Other | 2025-01-07 | Sale | 19,251.0 | $175.46 |
| Wang Xiaodong | Director,Other | 2024-12-10 | Sale | 300.0 | $195.67 |
| Wang Xiaodong | Director,Other | 2024-12-10 | Sale | 725.0 | $194.01 |
| Wang Xiaodong | Director,Other | 2024-12-10 | Sale | 1,374.0 | $192.61 |
| Wang Xiaodong | Director,Other | 2024-12-10 | Sale | 993.0 | $191.78 |
| Wang Xiaodong | Director,Other | 2024-12-10 | Sale | 1,833.0 | $190.57 |
| Wang Xiaodong | Director,Other | 2024-12-10 | Sale | 1,300.0 | $188.79 |
| Wang Xiaodong | Director,Other | 2024-12-10 | Sale | 6,350.0 | $187.6 |
| Wang Xiaodong | Director,Other | 2024-12-10 | Sale | 9,266.0 | $186.99 |
| Wang Xiaodong | Director,Other | 2024-12-10 | Sale | 9,956.0 | $185.73 |
| Wang Xiaodong | Director,Other | 2024-12-10 | Sale | 7,063.0 | $184.83 |
| Wang Xiaodong | Director,Other | 2024-12-10 | Sale | 2,600.0 | $183.6 |
| BAKER JULIAN | Director | 2024-12-09 | Sale | 916,964.0 | $186.5 |
| BAKER FELIX | Director | 2024-12-09 | Sale | 916,964.0 | $186.5 |
| BAKER BROS. ADVISORS LP | Director | 2024-12-09 | Sale | 916,964.0 | $186.5 |
| Baker Brothers Life Sciences LP | Director | 2024-12-09 | Sale | 916,964.0 | $186.5 |
| 667, L.P. | Director | 2024-12-09 | Sale | 916,964.0 | $186.5 |
| Baker Bros. Advisors (GP) LLC | Director | 2024-12-09 | Sale | 916,964.0 | $186.5 |
| BAKER JULIAN | Director | 2024-12-09 | Sale | 83,036.0 | $186.5 |
| BAKER FELIX | Director | 2024-12-09 | Sale | 83,036.0 | $186.5 |
| BAKER BROS. ADVISORS LP | Director | 2024-12-09 | Sale | 83,036.0 | $186.5 |
| Baker Brothers Life Sciences LP | Director | 2024-12-09 | Sale | 83,036.0 | $186.5 |
| 667, L.P. | Director | 2024-12-09 | Sale | 83,036.0 | $186.5 |
| Baker Bros. Advisors (GP) LLC | Director | 2024-12-09 | Sale | 83,036.0 | $186.5 |
| BAKER JULIAN | Director | 2024-12-09 | Sale | 33,943.0 | $208.01 |
| BAKER FELIX | Director | 2024-12-09 | Sale | 33,943.0 | $208.01 |
| BAKER BROS. ADVISORS LP | Director | 2024-12-09 | Sale | 33,943.0 | $208.01 |
| Baker Brothers Life Sciences LP | Director | 2024-12-09 | Sale | 33,943.0 | $208.01 |
| 667, L.P. | Director | 2024-12-09 | Sale | 33,943.0 | $208.01 |
| Baker Bros. Advisors (GP) LLC | Director | 2024-12-09 | Sale | 33,943.0 | $208.01 |
| BAKER JULIAN | Director | 2024-12-09 | Sale | 3,074.0 | $208.01 |
| BAKER FELIX | Director | 2024-12-09 | Sale | 3,074.0 | $208.01 |
| BAKER BROS. ADVISORS LP | Director | 2024-12-09 | Sale | 3,074.0 | $208.01 |
| Baker Brothers Life Sciences LP | Director | 2024-12-09 | Sale | 3,074.0 | $208.01 |
| 667, L.P. | Director | 2024-12-09 | Sale | 3,074.0 | $208.01 |
| Baker Bros. Advisors (GP) LLC | Director | 2024-12-09 | Sale | 3,074.0 | $208.01 |
| Wu Xiaobin | President, COO & GM China | 2024-12-06 | Sale | 0.0 | $0.0 |
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. | TenPercentOwner | 2024-12-02 | Sale | 17,842,500.0 | $200.0 |
| HHLR ADVISORS, LTD. | TenPercentOwner | 2024-12-02 | Sale | 17,842,500.0 | $200.0 |
| Wang Xiaodong | Director,Other | 2024-11-26 | Sale | 883.0 | $191.89 |
| Wang Xiaodong | Director,Other | 2024-11-26 | Sale | 2,725.0 | $191.24 |
| Wang Xiaodong | Director,Other | 2024-11-26 | Sale | 1,475.0 | $190.31 |
| Wang Xiaodong | Director,Other | 2024-11-26 | Sale | 600.0 | $189.03 |
| Wang Xiaodong | Director,Other | 2024-11-26 | Sale | 1,186.0 | $188.08 |
| Wang Xiaodong | Director,Other | 2024-11-26 | Sale | 1,014.0 | $187.15 |
| Wang Xiaodong | Director,Other | 2024-11-26 | Sale | 6,981.0 | $191.96 |
| Wang Xiaodong | Director,Other | 2024-11-26 | Sale | 407.0 | $191.81 |
| Wang Xiaodong | Director,Other | 2024-11-26 | Sale | 12,293.0 | $191.22 |
| Wang Xiaodong | Director,Other | 2024-11-26 | Sale | 700.0 | $191.05 |
| Wang Xiaodong | Director,Other | 2024-11-26 | Sale | 6,187.0 | $190.32 |
| Wang Xiaodong | Director,Other | 2024-11-26 | Sale | 200.0 | $189.76 |
| Wang Xiaodong | Director,Other | 2024-11-26 | Sale | 2,700.0 | $189.17 |
| Wang Xiaodong | Director,Other | 2024-11-26 | Sale | 400.0 | $188.55 |
| Wang Xiaodong | Director,Other | 2024-11-26 | Sale | 5,875.0 | $187.98 |
| Wang Xiaodong | Director,Other | 2024-11-26 | Sale | 300.0 | $187.61 |
| Wang Xiaodong | Director,Other | 2024-11-26 | Sale | 4,425.0 | $187.16 |
| OYLER JOHN | Chief Executive Officer | 2024-10-08 | Sale | 1,452.0 | $236.37 |
| OYLER JOHN | Chief Executive Officer | 2024-10-08 | Sale | 2,059.0 | $235.41 |
| OYLER JOHN | Chief Executive Officer | 2024-10-08 | Sale | 694.0 | $234.27 |
| OYLER JOHN | Chief Executive Officer | 2024-10-08 | Sale | 62.0 | $233.0 |
| OYLER JOHN | Chief Executive Officer | 2024-10-08 | Sale | 371.0 | $231.04 |
| OYLER JOHN | Chief Executive Officer | 2024-10-08 | Sale | 2,827.0 | $230.05 |
| OYLER JOHN | Chief Executive Officer | 2024-10-08 | Sale | 2,535.0 | $229.25 |
| OYLER JOHN | Chief Executive Officer | 2024-10-08 | Sale | 896.0 | $236.37 |
| OYLER JOHN | Chief Executive Officer | 2024-10-08 | Sale | 1,272.0 | $235.41 |
| OYLER JOHN | Chief Executive Officer | 2024-10-08 | Sale | 428.0 | $234.27 |
| OYLER JOHN | Chief Executive Officer | 2024-10-08 | Sale | 38.0 | $233.0 |
| OYLER JOHN | Chief Executive Officer | 2024-10-08 | Sale | 229.0 | $231.05 |
| OYLER JOHN | Chief Executive Officer | 2024-10-08 | Sale | 1,747.0 | $230.05 |
| OYLER JOHN | Chief Executive Officer | 2024-10-08 | Sale | 1,565.0 | $229.25 |
| Lee Chan Henry | SVP, General Counsel | 2024-09-30 | Sale | 1,202.0 | $237.1 |
| Wang Lai | Global Head of R&D | 2024-09-27 | Sale | 5,000.0 | $220.35 |
| Wu Xiaobin | President, COO & GM China | 2024-09-19 | Sale | 4,500.0 | $200.14 |
| Wu Xiaobin | President, COO & GM China | 2024-09-17 | Sale | 500.0 | $200.0 |
| Wu Xiaobin | President, COO & GM China | 2024-09-03 | Sale | 274.0 | $192.04 |
| Wu Xiaobin | President, COO & GM China | 2024-09-03 | Sale | 700.0 | $191.2 |
| Wu Xiaobin | President, COO & GM China | 2024-09-03 | Sale | 2,275.0 | $190.29 |
| Wu Xiaobin | President, COO & GM China | 2024-09-03 | Sale | 275.0 | $188.97 |
| Wu Xiaobin | President, COO & GM China | 2024-09-03 | Sale | 2,032.0 | $188.16 |
| Ball Titus B. | Principal Accounting Officer | 2024-09-03 | Sale | 137.0 | $189.94 |
| Lee Chan Henry | SVP, General Counsel | 2024-07-30 | Sale | 834.0 | $160.57 |
| Wang Julia Aijun | Chief Financial Officer | 2024-07-01 | Sale | 472.0 | $143.9 |
| Wang Julia Aijun | Chief Financial Officer | 2024-06-24 | Sale | 899.0 | $155.66 |
| Wang Lai | Global Head of R&D | 2024-06-24 | Sale | 2.0 | $161.1 |
| Wang Lai | Global Head of R&D | 2024-06-24 | Sale | 1,062.0 | $159.8 |
| Wu Xiaobin | President, COO & GM China | 2024-06-24 | Sale | 23.0 | $161.27 |
| Wu Xiaobin | President, COO & GM China | 2024-06-24 | Sale | 400.0 | $160.38 |
| Wu Xiaobin | President, COO & GM China | 2024-06-24 | Sale | 1,036.0 | $159.53 |
| OYLER JOHN | Chief Executive Officer | 2024-06-24 | Sale | 400.0 | $160.12 |
| OYLER JOHN | Chief Executive Officer | 2024-06-24 | Sale | 2,389.0 | $159.49 |
| Wang Lai | Global Head of R&D | 2024-06-18 | Sale | 841.0 | $153.75 |
| Wu Xiaobin | President, COO & GM China | 2024-06-18 | Sale | 300.0 | $156.8 |
| Wu Xiaobin | President, COO & GM China | 2024-06-18 | Sale | 300.0 | $155.15 |
| Wu Xiaobin | President, COO & GM China | 2024-06-18 | Sale | 906.0 | $154.17 |
| Wu Xiaobin | President, COO & GM China | 2024-06-18 | Sale | 1,121.0 | $153.66 |
| OYLER JOHN | Chief Executive Officer | 2024-06-17 | Sale | 376.0 | $159.91 |
| OYLER JOHN | Chief Executive Officer | 2024-06-17 | Sale | 608.0 | $159.4 |